Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical research

Microplastics found in lung cancer patients

Analysis based on 8 articles · First reported Sep 03, 2026 · Last updated Sep 22, 2026

Sentiment
-10
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The findings may increase public and regulatory attention on plastic pollution and its health impacts, potentially affecting industries reliant on plastics such as packaging and textiles. However, as an early-stage research finding, immediate market impact is limited, though it could influence future environmental regulations and healthcare research funding.

Healthcare Environmental

Research presented at the European Respiratory Society Congress in Barcelona, Spain, found that patients with lung cancer are more likely to have microplastics in their lungs and in larger quantities than those without cancer. The study, led by Dr Ilias Dimeas from University College Dublin and the University of Thessaly, analyzed lung samples from 100 patients at University Hospital of Larissa in Greece. Of these, 50 were diagnosed with lung cancer. Microplastics were detected in 70% of all patients, with lung cancer patients showing higher detection rates (66% vs 46%) and greater overall burden. Polypropylene and polyethylene were the most common types found. The study suggests microplastics may enter the body through inhalation and could be linked to lung disease, though causality is not established. Researchers are conducting further experiments to understand interactions with lung cells. Professor Barbara Hoffmann of the Heinrich Heine University Düsseldorf and the European Respiratory Society Advocacy Council commented on the findings, emphasizing the need for more research and advocating for clean air.

per
Lead researcher who presented the study and is conducting further experiments.
Importance 80.0 Sentiment 0.0
ngo
Hosted the congress where the research was presented; its Advocacy Council chair commented on the findings.
Importance 60.0 Sentiment 0.0
oth
Site where patient samples were collected, providing the clinical data for the study.
Importance 60.0 Sentiment 0.0
oth
Affiliated institution of lead researcher Dr Ilias Dimeas, involved in conducting the research.
Importance 50.0 Sentiment 0.0
per
Provided independent expert commentary, highlighting the need for more research.
Importance 40.0 Sentiment 0.0
cnt
Country where the study was conducted, at University Hospital of Larissa.
Importance 40.0 Sentiment 0.0
oth
Institution of Professor Barbara Hoffmann, who provided expert commentary.
Importance 30.0 Sentiment 0.0
cnt
Country of lead researcher's affiliated institution, University College Dublin.
Importance 20.0 Sentiment 0.0
cnt
Host country of the European Respiratory Society Congress where findings were presented.
Importance 20.0 Sentiment 0.0
cnt
Country of Professor Barbara Hoffmann's institution, Heinrich Heine University Düsseldorf.
Importance 20.0 Sentiment 0.0
Greece related ↔ Spain
Greece related ↔ Germany
Spain related ↔ Germany
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.